Stockreport

The Bull Case For Pfizer (PFE) Could Change Following New First-Line BRAFTOVI Colorectal Cancer Approval [Yahoo! Finance]

Pfizer, Inc.  (PFE) 
Last pfizer, inc. earnings: 4/28 06:45 am Check Earnings Report
PDF chemotherapy to treat adults with BRAF V600E-mutant metastatic colorectal cancer, upgrading its prior accelerated approval based on outcomes from the Phase 3 BREAKWATER [Read more]